Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
4,404,649
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
2,190,280
-
Shares change
-
+354,773
-
Total reported value, excl. options
-
$31,692,000
-
Value change
-
+$5,245,036
-
Number of buys
-
11
-
Number of sells
-
-6
-
Price
-
$14.47
Significant Holders of Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST) as of Q3 2021
23 filings reported holding TPST - Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q3 2021.
Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,190,280 shares
of 4,404,649 outstanding shares and own 49.7% of the company stock.
Largest 10 shareholders include FMR LLC (647,898 shares), VANGUARD GROUP INC (359,166 shares), Rock Springs Capital Management LP (310,161 shares), Foresite Capital Management IV, LLC (190,213 shares), FIL Ltd (129,579 shares), Maven Securities LTD (126,883 shares), NEA Management Company, LLC (117,785 shares), BlackRock Inc. (82,698 shares), Monashee Investment Management LLC (60,000 shares), and Ikarian Capital, LLC (58,803 shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.